Trials / Completed
CompletedNCT02336854
Tacrobell tab_Phase1_PK
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, two-way crossover study to assess the tolerability and pharmacokinetics of Tacrobell® Tab. and Prograf® Cap. after a single oral dose in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrobell tab. 2mg | |
| DRUG | Prograf cap. 2mg |
Timeline
- Start date
- 2015-01-12
- Primary completion
- 2015-02-02
- Completion
- 2015-03-19
- First posted
- 2015-01-13
- Last updated
- 2017-08-08
Source: ClinicalTrials.gov record NCT02336854. Inclusion in this directory is not an endorsement.